Liveome
PrivateLast Round
Series A
Apr 21, 2022
Total Funding Raised
$5.6M
Company Overview
Liveome operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Series A round in April 2022.
Liveome is a biotechnology company that develops next-generation microbiome therapeutics and gene-recombinant microbiome drugs for the treatment of inflammatory and incurable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Liveome Comparables
Compare Liveome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoBiome Inc. | 89% | |
| AtoGen Co., Ltd. | 77% | |
| Nodcure Inc. | 77% |
For institutional investors. Book with your work email.
Liveome Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Liveome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lindeman Asia Investment | Series A |
Liveome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Liveome's valuation, stock price, and market status.
Is Liveome a public or private company?
Liveome is a private company.
What is the current stock price of Liveome?
Liveome is a private company, so its shares have no public market price. Caplight tracks Liveome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Liveome worth (valuation)?
Valuation information for Liveome is not publicly available.
Can I buy Liveome stock?
Liveome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Liveome's last funding round?
Liveome's most recent funding round was Series A on April 21, 2022.
Who are the main investors in Liveome?
Key investors in Liveome include Lindeman Asia Investment.
Will Liveome IPO soon?
No public IPO plans have been announced for Liveome.
How can I track Liveome secondary market activity?
Caplight tracks bids, offers, and trades in Liveome's shares on secondary markets.